Patrick Daugherty Discusses Rush to Relist Ripple’s XRP Following Crypto Court Ruling
14 July 2023
Blockworks
Foley & Lardner LLP partner Patrick Daugherty is quoted in the Blockworks article, “Exchanges rush to relist XRP, but an SEC appeal is possible,” discussing the move by some cryptocurrency exchanges to relist Ripple’s XRP token following a partial summary judgement by a federal judge in favor of the company that held the asset is not a security when traded on exchanges.
Daugherty said the relistings were not surprising. “The SEC lost everything that mattered,” he stated. “The only part of the case that Ripple lost had nothing whatsoever to do with exchange trading.”
Daugherty noted, however, that there might be concerns around a potential appeal of the decision by the SEC. He added that the success of an appeal would be unlikely.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."